SLC7A11 and Kaposi's sarcoma: Remarkably, we did not detect any changes in the expression level of SLC7A11 in KMM cells, which contradicts the previously reported upregulation of SLC7A11 in KS lesions or KSHV-infected PEL cells [46–49].